Drug adherence in the elderly: Determinants and support;L'adhésion thérapeutique du patient âgé ambulatoire: Quels déterminants et quel soutien?

Revue Medicale Suisse

Volumn 2, Issue 56, 2006, Pages 664-670

  Schneider, Marie Paule ^a   Locca, Jean François ^a   Bugnon, Olivier ^a   Conzelmann, Martin ^b  

^a POLICLINIQUE MÉDICALE UNIVERSITAIRE   (Switzerland)

^b Felix Platter Spital ^*  (Burkina Faso)

Author keywords

[No Author keywords available]

Indexed keywords

ACENOCOUMAROL; ACETYLSALICYLIC ACID; ATORVASTATIN; CITALOPRAM; DIGOXIN; METFORMIN; TORASEMIDE; ZOLPIDEM TARTRATE;

ARTICLE; ELDERLY CARE; HEALTH PRACTITIONER; HUMAN; MEDICAL DECISION MAKING; MEDICAL PRACTICE; OPEN ENDED QUESTIONNAIRE; PATIENT COMPLIANCE; TREATMENT PLANNING; AGED; DRUG THERAPY; PATIENT CARE; REVIEW;

AGED; DRUG THERAPY; HUMANS; PATIENT CARE TEAM; PATIENT COMPLIANCE;

EID: 33646190519     PISSN: 16609379     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Claesson S, Morrison A, Wertheimer AI, Berger ML. Compliance with prescribed drugs: Challenges for the elderly population. Pharm World Sci 1999;21:256-9.
2. Vik SA, Maxwell CJ, Hogan DB. Measurement, correlates, and health outcomes of medication adherence among seniors. Ann Pharmacother 2004;38:303-12.
3. Gurwitz JH, Field TS, Harrold LR, et al. Incidence and preventability of adverse drug events among older persons in the ambulatory setting. JAMA 2003;289:1107-16.
4. Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients: A meta-analysis of prospective studies. JAMA 1998;279:1200-5.
5. Mannesse CK, Derkx FH, de Ridder MA, Man in't Veld AJ, van der Cammen TJ. Adverse drug reactions in elderly patients as contributing factor for hospital admission: Cross sectional study. BMJ 1997;315:1057-8.
6. Michalsen A, Konig G, Thimme W. Preventable causative factors leading to hospital admission with decompensated heart failure. Heart 1998;80:437-41.
7. Piette JD, Heisler M, Krein S, Kerr EA. The role of patient-physician trust in moderating medication non-adherence due to cost pressures. Arch Intern Med 2005;165:1749-55.
8. Leventhal H, Safer MA, Panagis DM. The impact of communications on the self-regulation of health beliefs, decisions, and behavior. Health Educ Q 1983;10:3-29.
9. Leventhal H. The role of theory in the study of adherence to treatment and doctor-patient interactions. Med Care 1985;23:556-63.
10. Kimberlin C, Assa M, Rubin D, Zaenger P. Questions elderly patients have about on-going therapy: A pilot study to assist in communication with physicians. Pharm World Sci 2001;23:237-41.
11. Leger S, Bedouch B, Allenet J, Calop J. Culture pharmaceutique, perception du traitement médicamenteux et difficultés de consommation des médicaments chez le sujet âgé. J Pharm Clin 2001;20:110-3.
12. Beckman AG, Parker MG, Thorslund M. Can elderly people take their medicine? Patient Educ Couns 2005;59:186-91.
13. Biollaz J, Buclin T. Polypathologies: faut-il tout traiter? Rev Med Suisse 2005;1:941-7.
14. Fleury J, Cameron K. The Index of Readiness. In: Strickland O.L, Dilorio C, eds. Measurement of Nursing Outcomes. 2nd ed. New York: Springer Publishing Company, 2003;265-75.
15. Michel JP. Enjeux du partenariat pour les soins gériatriques. Med Hyg 2002;60:2147.
16. Rollason V, Bonnabry P, Vogt N. Réduire la plurimédication chez la personne âgée: du vœu pieux à des solutions applicables. Med Hyg 2000;58:818-25.